Skip to main content
. 2023 Nov 24;10:61. doi: 10.1186/s40621-023-00473-2

Table 2.

Characteristics of First-Ranked Loperamide Cases Reported to US Poison Centers by Reason for Exposure, National Poison Data System 2010–2022

Characteristics Unintentional reasons Intentional reasons
General
n (%)a
Therapeutic Error
n (%)a
Misuse
n (%)a
Otherf
n (%)a
Suspected Suicide
n (%)a
Misuse
n (%)a
Abuse
n (%)a
Unknown
n (%)a
Other
n (%)a
Unknown
n
Total
n (%)b
Sex
Male 3,111 (51.1) 891 (14.6) 139 (2.3) 6 (0.1) 436 (7.2) 497 (8.2) 676 (11.1) 91 (1.5) 246 (4.0) 57 6,150 (47.5)
Female 3,224 (48.0) 1,273 (19.0) 162 (2.4) 18 (0.3) 664 (9.9) 591 (8.8) 293 (4.4) 96 (1.4) 394 (5.9) 72 6,787 (52.5)
Unknown 25 5 0 1 6 4 3 3 3 50
Exposure type
Single-substance 5,796 (52.0) 2,043 (18.3) 279 (2.5) 21 (0.2) 581 (5.2) 965 (8.7) 762 (6.8) 149 (1.3) 544 (4.9) 108 11,248 (86.6)
Multiple-substance 564 (32.9) 126 (7.3) 22 (1.3) 4 (0.2) 525 (30.6) 127 (7.4) 210 (12.2) 41 (2.4) 96 (5.6) 24 1,739 (13.4)
Highest level of health care received
No HCF treatment received 4,342 (59.9) 1,845 (25.5) 195 (2.7) 8 (0.1) 6 (0.1) 351 (4.8) 46 (0.6) 29 (0.4) 424 (5.9) 22 7,268 (60.3)
Treated/ evaluated and released 1,344 (55.5) 159 (6.6) 45 (1.9) 4 (0.2) 276 (11.4) 278 (11.5) 221 (9.1) 30 (1.2) 63 (2.6) 15 2,435 (20.2)
Admitted to a HCF 205 (10.9) 44 (2.3) 21 (1.1) 11 (0.6) 687 (36.7) 236 (12.6) 551 (29.4) 87 (4.6) 32 (1.7) 60 1,934 (16.0)
 CCU 61 (6.5) 15 (1.6) 7 (0.7) 7 (0.7) 268 (28.4) 123 (13.0) 393 (41.6) 55 (5.8) 15 (1.6) 35 979 (8.1)
 Non-CCU 133 (22.7) 28 (4.8) 12 (2.1) 4 (0.7) 161 (27.5) 93 (15.9) 118 (20.2) 23 (3.9) 13 (2.2) 22 607 (5.0)
 Psychiatric facility 11 (3.2) 1 (0.3) 2 (0.6) 0 (0.0) 258 (74.8) 20 (5.8) 40 (11.6) 9 (2.6) 4 (1.2) 3 348 (2.9)
Patient refused referral/did not arrive at a HCF 173 (41.8) 41 (9.9) 13 (3.1) 2 (0.5) 41 (9.9) 63 (15.2) 38 (9.2) 15 (3.6) 28 (6.8) 9 423 (3.5)
Patient lost to follow-up/Left against medical advice/Unknown 296 80 27 0 96 164 116 29 93 26 927
Medical outcome
No effect 3,016 (73.6) 434 (10.6) 57 (1.4) 2 (0.0) 286 (7.0) 188 (4.6) 69 (1.7) 20 (0.5) 28 (0.7) 16 4,116 (34.4)
Minor effect 366 (26.5) 204 (14.8) 41 (3.0) 3 (0.2) 245 (17.7) 207 (15.0) 139 (10.1) 30 (2.2) 146 (10.6) 19 1,400 (11.7)
Serious medical outcomec 73 (4.7) 40 (2.6) 27 (1.7) 11 (0.7) 426 (27.5) 243 (15.7) 589 (38.0) 78 (5.0) 64 (4.1) 52 1,603 (13.4)
 Moderate effect 65 (6.3) 34 (3.3) 19 (1.8) 4 (0.4) 288 (27.7) 191 (18.4) 342 (32.9) 38 (3.7) 57 (5.5) 26 1,064 (8.9)
 Major effect 8 (1.7) 6 (1.3) 6 (1.3) 7 (1.5) 127 (27.7) 49 (10.7) 214 (46.7) 34 (7.4) 7 (1.5) 22 480 (4.0)
 Death 0 (0.0) 0 (0.0) 2 (3.6) 0 (0.0) 11 (20.0) 3 (5.5) 33 (60.0) 6 (10.9) 0 (0.0) 4 59 (0.5)
Not followedd 2,508 (51.8) 1,418 (29.3) 162 (3.3) 6 (0.1) 27 (0.6) 301 (6.2) 54 (1.1) 26 (0.5) 337 (7.0) 18 4,857 (40.6)
Unable to followe 397 73 14 3 122 153 121 36 65 27 1,011
Total (row %) 6,360 (49.5) 2,169 (16.9) 301 (2.3) 25 (0.2) 1,106 (8.6) 1,092 (8.5) 972 (7.6) 190 (1.5) 640 (5.0) 132 12,987 (100.0)

CCU—Critical Care Unit, HCF—Health Care Facility

aRow percentage may not add to 100.0% due to rounding error

bColumn percentage may not add up to 100.0% due to rounding error

cIncludes moderate effect, major effect, and death

dNot followed (minimal clinical effects possible)

eUnable to follow (judged as a potentially toxic exposure)

fIncludes unintentional-environmental, unintentional-occupational, and unintentional-unknown